Navigation Links
InterMune Reports Third Quarter 2010 Financial Results
Date:10/28/2010

BRISBANE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced results from operations for the third quarter and nine months ended September 30, 2010.  InterMune also highlighted its recent clinical development, regulatory and business activities, and provided updated forward-looking financial guidance for 2010.  

Dan Welch, Chairman, Chief Executive Officer and President of InterMune said, "Earlier this month we announced the sale of our rights to danoprevir to Roche for $175 million, a very significant non-dilutive cash infusion that provides the financial strength and flexibility to independently pursue the registration and commercialization of pirfenidone.  Our Marketing Authorization Application (MAA) for pirfenidone is proceeding on schedule and on October 15 we submitted our responses to the CHMP's Day 120 List of Questions.  We continue to anticipate a decision on the pirfenidone MAA from the European authorities in the first half of 2011.  Regarding our U.S. registration strategy for pirfenidone, we plan to provide an update next quarter."Recent Clinical Development, Business Highlights and Upcoming Milestones  Pirfenidone:  

  • InterMune reported today that on October 15, the company submitted its responses to the Day 120 List of Questions from the Committee for Medicinal Products for Human Use (CHMP).  InterMune currently anticipates a decision on the pirfenidone MAA from the European authorities in the first half of 2011.

  • Danoprevir:

  • Danoprevir (also known as RG7227 and ITMN-191) is a protease inhibitor for the treatment of patients chronically infected with the hepatitis C virus (HCV).  On October 6, 2010, the company announced that it had sold worldwide development and commercialization rights to danoprevir to Hoffmann-La Roche Inc. and F. Hoff
    '/>"/>

  • SOURCE InterMune, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
    2. InterMune to Release Second Quarter Financial Results on July 27
    3. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
    4. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
    5. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
    6. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
    7. InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
    8. InterMune to Present at Deutsche Bank Biotech Confab
    9. InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
    10. InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF
    11. InterMune to Present at JMP Securities Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... BIRMINGHAM, Ala. , Jan. 23, 2015 Gem ... (STS) patients have been enrolled into the Company,s Phase ... efficacy and safety of Gem,s lead compound, GPX-150 (an ... for advanced or metastatic disease. Logo - ...
    (Date:1/22/2015)... 2015  BiOptix is pleased to announce the appointment of ... Chemistry and Biochemistry. Scott joins the company after previous scientific ... throughout the course of his nearly 20 year career ... a nationally recognized thought leader in the biosensor field ...
    (Date:1/22/2015)... 22, 2015  Amgen (NASDAQ: AMGN ) today announced that ... results on Tuesday, Jan. 27, 2015, after the close of the ... call with the investment community at 2 p.m. PT. Participating in ... chairman and chief executive officer, and other members of Amgen,s senior ...
    Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
    ... ,France: +33(0)1-70-99-42-73 ,U.K.: +44(0)20-7136-2052 ,USA: +1-212-444-0481 ,The dial-in ... webcast and presentation, log onto: http://www.sartorius.com ... 2011    Publication of the nine-month figures (January ... contains statements about the future development of the ...
    ... 25, 2011 /PRNewswire-Asia/ -- The whole healthcare market is ... and social economic increases. Generally speaking, several changes can ... of world population especially the aging population , ... in both developed and developing countries. They urgently require ...
    Cached Medicine Technology:Successful First Half of 2011: Sartorius Raises Full-year Guidance 2Avoid Illness Through Easy Daily Check 2
    (Date:1/22/2015)... 22, 2015 Liberty University has received accreditation ... program from the Council for Accreditation of Counseling & ... Liberty’s Center for Counseling & Family Studies , is ... the university’s new School of Behavioral Sciences. Prior to the ...
    (Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located in ... number one best large hotel for families in the United ... annual Travelers’ Choice Awards. , TripAdvisor represents the world’s ... to millions of unbiased and honest traveler reviews. The best ...
    (Date:1/22/2015)... is a seasoned and trusted leader who consistently delivers trendy ... have it lead the wedding dress industry into the future. ... for the global market. , “The CEO of VogueQueen is ... on continuing the goal of operational excellence and giving back ...
    (Date:1/22/2015)... January 22, 2015 Blue Cross and Blue ... who exemplify what it means to “Live Fearless.” ... people to share their stories about how they or someone ... inspired others by living in the moment. By telling these ...
    (Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
    Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
    ... of America (GSA) invites all journalists to attend its ... interdisciplinary conference in the field of aging from November ... free of charge. An estimated 3,500 professionals are expected ... and Atlanta Marriott Marquis . The theme for ...
    ... 10, 2009) The University of Miami School of Nursing and ... T. Macdonald Foundation in the amount of $30,000 to support ... of Nursing program. "Family nurse practitioners have a promising future" ... and Health Studies. "The Dr. John T. Macdonald Foundation grant ...
    ... , , , LAKE FOREST, ... a leading global specialty pharmaceutical and medication delivery company, today announced ... Chicago on Thursday, Sept. 17, 2009. The company,s senior leadership team ... , , A streaming audio webcast of the ...
    ... , , SALT ... implant and instrument company focused on unique silicon nitride ceramic technologies, ... sq. ft. global headquarters. , , Bucking the ... need for the new larger multifunctional facility. Amedica believes the ...
    ... , , MUMBAI, India and PRAGUE, ... with a base in India, US, Europe and Israel today announced ... , , "Czech Republic has an excellent resource ... Strategic Operations, Europe. "Our new office in Czech Republic will further ...
    ... BOSTON, Sept. 10 Purchasers of pharmaceutical drugs ... of benchmark prices of some of the most common prescription ... approval of a settlement with two leading drug-pricing publishers, First ... Inc. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ) ...
    Cached Medicine News:Health News:An invitation to the nation's premier aging conference 2Health News:UM receives grant to support graduate students in the family nurse practitioner program 2Health News:Hospira to Host 2009 Investor Day 2Health News:Amedica Announces New Global Headquarters 2Health News:SIRO Clinpharm Expands Operations in Europe 2Health News:Major Rollback of Pharmaceutical Bench Mark Prices Approved by Federal Court of Appeals, Hagens Berman Announces 2Health News:Major Rollback of Pharmaceutical Bench Mark Prices Approved by Federal Court of Appeals, Hagens Berman Announces 3Health News:Major Rollback of Pharmaceutical Bench Mark Prices Approved by Federal Court of Appeals, Hagens Berman Announces 4
    AHFS Patient Drug Information gives you a single source for providing important information and instructions for patients on dosing, precautions, possible side effects and interactions, and more....
    Containing more than 600 full drug monographs, plus abbreviated monographs for combination drugs, orphan drugs and AIDS drugs in development, A to Z Drug Facts provides up-to-date information on more...
    Provides instant access to reliable information on herbs, minerals, vitamins, amino acids, probiotics, enzymes, over-the-counter hormones, and other dietary supplements commonly used by consumers....
    Updated for 2006 with more than 800 complete drug entries, this mobile reference provides instant access to all the drug information nurses need in day-to-day practice....
    Medicine Products: